AG
BDSI

Aperio Group’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Aperio Group’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$88K Sell
20,877
-6,448
-24% -$24.8K ﹤0.01% 2386
2020
Q3 		$102K Buy
27,325
+9,622
+54% +$40.9K ﹤0.01% 2319
2020
Q2 		$77K Buy
+17,703
New +$79.6K ﹤0.01% 2285
2019
Q3 		– Sell
-2,440
Closed -$11K – 3057
2019
Q2 		$11K Buy
+2,440
New +$11.4K ﹤0.01% 2778

Other funds holding BDSI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Aperio Group's BDSI Position: Q4 2020 in Review

Aperio Group reduced its BioDelivery Sciences International, Inc. (BDSI) stake by 24% in Q4 2020, selling an estimated $24.8K and leaving 20,877 shares worth $88K. The position accounts for ﹤0.01% of the portfolio, ranked #2386.

Aperio Group first reported a position in BDSI in Q2 2019 and has held it in 4 quarters since. The position peaked at $102K in Q3 2020. 145 funds tracked by Wall St. Rank hold BDSI as of Q4 2020.

  • Aperio Group held 20,877 shares of BioDelivery Sciences International, Inc. worth $88K as of Q4 2020.
  • Aperio Group sold 6,448 BioDelivery Sciences International, Inc. shares in Q4 2020, an estimated $24.8K.
  • BioDelivery Sciences International, Inc. made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2386 holding.
  • Aperio Group first reported a position in BioDelivery Sciences International, Inc. in Q2 2019 and has held it in 4 quarters since.
  • Aperio Group's BioDelivery Sciences International, Inc. position peaked at $102K in Q3 2020.
  • 145 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.